Beyond hype: How systemic bias, funding structures, and global health inequities shape AI’s role in medicine
Original framing: “Opinion: Stop asking if AI is good for medicine” — STAT News
Rigorous scientific evaluation demands external validation, transparent reporting of bias metrics, and longitudinal outcome studies. Current literature often relies on retrospective datasets that lack representativeness, inflating performance claims and masking real‑world failure modes.
The hype surrounding AI in medicine masks a web of structural biases, commercial incentives, and colonial data practices that perpetuate health inequities.
By foregrounding Indigenous data sovereignty, historical lessons from past medical technologies, and cross‑cultural governance models, we can redesign AI pipelines to be transparent, accountable, and culturally attuned. Robust scientific validation, coupled with artistic‑spiritual critique and trickster‑style inversion, exposes the absurdity of treating AI as a universal cure. Implementing community‑governed data trusts, mandatory bias audits, co‑design labs, and green AI incentives offers concrete pathways to align technological innovation with social justice and planetary health.